This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
這位愛德斯分析師以看好的態度開始覆蓋；以下是週一的五個重點啓動。
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
頂級華爾街分析師改變了他們對這些頂級股票的看法。有關所有分析師評級變動的完整信息，包括評級上調和下調，請查看我們的分析師評級頁面。
- Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc. (NYSE:GRND) with a Buy rating and announced a price target of $20. Grindr shares closed at $15.74 on Friday. See how other analysts view this stock.
- JMP Securities analyst Constantine Davides initiated coverage on Addus HomeCare Corporation (NASDAQ:ADUS) with a Market Outperform rating and announced a price target of $150. Addus HomeCare shares closed at $125.00 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Matthew Caufield initiated coverage on Zenas BioPharma, Inc. (NASDAQ:ZBIO) with a Buy rating and announced a price target of $30. Zenas BioPharma shares closed at $8.92 on Friday. See how other analysts view this stock.
- JMP Securities analyst Constantine Davides initiated coverage on U.S. Physical Therapy, Inc. (NYSE:USPH) with a Market Outperform rating and announced a price target of $113. US Physical Therapy shares closed at $93.46 on Friday. See how other analysts view this stock.
- Jones Trading analyst Justin Walsh initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $18. Alto Neuroscience shares closed at $3.83 on Friday. See how other analysts view this stock.
- 高盛的分析師埃裏克·謝里登對Grindr Inc.（紐交所：GRND）進行了覆蓋，給出了買入評級，並宣佈了20美元的目標價。Grindr的股票在週五收盤時爲15.74美元。看看其他分析師對這隻股票的看法。
- JMP證券的分析師康斯坦丁·達維德斯對愛德斯（NASDAQ：ADUS）進行了覆蓋，給出了市場優於大盤的評級，並宣佈了150美元的目標價。愛德斯的股票在週五收盤時爲125.00美元。看看其他分析師對這隻股票的看法。
- HC Wainwright & Co.的分析師馬修·考菲爾德對Zenas BioPharma, Inc.（NASDAQ：ZBIO）進行了覆蓋，給出了買入評級，並宣佈了30美元的目標價。Zenas BioPharma的股票在週五收盤時爲8.92美元。看看其他分析師對這隻股票的看法。
- JMP證券的分析師康斯坦丁·達維德斯對美國理療保健公司（NYSE：USPH）進行了覆蓋，給出了市場優於大盤的評級，並宣佈了113美元的目標價。美國理療保健的股票在週五收盤時爲93.46美元。看看其他分析師對這隻股票的看法。
- 瓊斯交易公司的分析師賈斯廷·沃爾什對Alto Neuroscience, Inc.（NYSE：ANRO）進行了覆蓋，給出了買入評級，並宣佈了18美元的目標價。Alto Neuroscience的股票在週五收盤時爲3.83美元。看看其他分析師對這隻股票的看法。
Considering buying ADUS stock? Here's what analysts think:
考慮購買ADUS股票嗎？以下是分析師的看法：
Read This Next: Wall Street's Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields
接下來閱讀：華爾街最準的分析師對3只超過6%股息收益率的能源股票的看法
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。